The journal’s editor issued a “temporary removal” of the paper after receiving complaints about its accuracy, though the authors maintain there are no errors in the data. The authors told The New York Times the corrections requested were to manage the specialty’s reputation. The journal said it asked the authors to remove “identifiable references to influential dermatologists,” according to the report.
The paper was published Oct. 5 and removed eight days later. As of Oct. 29, the paper is still removed from the site.
Here are the key findings of the paper, according to The New York Times:
- Private equity firms often acquire dermatology practices that perform high rates of well-reimbursed procedures.
- The paper does not assert if private equity firms are aware the high billing is unusual
- After private equity firms back a dermatology practice, those practices often open or buy pathology labs
- Leaders in the dermatology field are recruited by practices backed by private equity
Read the full story here.
More articles on finance:
Man breaks hip, then gets in on hospital employees’ $1M lottery winning
4 notable donations to healthcare organizations
LifePoint sees net income decline 19% in Q3
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
